Evidence map›Paper›PMID 32231135›Full record

ArticleCancers2020

Hypoxia and Macrophages Act in Concert Towards a Beneficial Outcome in Colon Cancer.

Flávia Martins, Rosa Oliveira, Bruno Cavadas, Filipe Pinto, Ana Patrícia Cardoso, Flávia Castro, Bárbara Sousa, Marta Laranjeiro Pinto, Ana João Silva, Diogo Adão and 6 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Current computer-aided drug design · 2025
    Article
  6. Review
  7. Review
  8. Deciphering the role of CD47 in cancer immunotherapy.Journal of advanced research · 2024
    Review
  9. Review
  10. Article
  11. CD47 (Cluster of Differentiation 47).Atlas of genetics and cytogenetics in oncology and haematology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 2 countries.

Flávia Martinsi3S-Institute for Research and Innovation in Health, University of Porto, 4200-135 Porto, Portugal.
Rosa Oliveirai3S-Institute for Research and Innovation in Health, University of Porto, 4200-135 Porto, Portugal.
Bruno Cavadasi3S-Institute for Research and Innovation in Health, University of Porto, 4200-135 Porto, Portugal.
Filipe Pintoi3S-Institute for Research and Innovation in Health, University of Porto, 4200-135 Porto, Portugal.
Ana Patrícia Cardosoi3S-Institute for Research and Innovation in Health, University of Porto, 4200-135 Porto, Portugal.
Flávia Castroi3S-Institute for Research and Innovation in Health, University of Porto, 4200-135 Porto, Portugal.
Bárbara Sousai3S-Institute for Research and Innovation in Health, University of Porto, 4200-135 Porto, Portugal.
Marta Laranjeiro Pintoi3S-Institute for Research and Innovation in Health, University of Porto, 4200-135 Porto, Portugal.
Ana João Silvai3S-Institute for Research and Innovation in Health, University of Porto, 4200-135 Porto, Portugal.
Diogo Adãoi3S-Institute for Research and Innovation in Health, University of Porto, 4200-135 Porto, Portugal.
José Pedro Loureiroi3S-Institute for Research and Innovation in Health, University of Porto, 4200-135 Porto, Portugal.
Nicole Pedroi3S-Institute for Research and Innovation in Health, University of Porto, 4200-135 Porto, Portugal.
Rui Manuel ReisMolecular Oncology Research Center, Barretos Cancer Hospital, Barretos-SP 14.784-400, Brazil.
Luísa Pereirai3S-Institute for Research and Innovation in Health, University of Porto, 4200-135 Porto, Portugal.
Maria José Oliveirai3S-Institute for Research and Innovation in Health, University of Porto, 4200-135 Porto, Portugal.
Angela Margarida Costai3S-Institute for Research and Innovation in Health, University of Porto, 4200-135 Porto, Portugal.
Universidade do Porto · PTHospital de Câncer de Barretos · BR

Funding

Fundação para a Ciência e a Tecnologia POCI-01-0145-FEDER-031859 (MAGICIAM)
6 · The paper itself

Abstract

In colon cancer, the prognostic value of macrophages is controversial, and it is still unknown how hypoxia modulates macrophage-cancer cell crosstalk. To unravel this, co-cultures of human primary macrophages and colon cancer cells were performed at 20% and 1% O

Indexed as

colon cancerhypoxiaimmune cell infiltrationmacrophagesprognosistumor microenvironment

Identifiers

PMID32231135
PMCPMC7226541
OpenAlexW3013819087

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.